Trump’s reciprocal tariff announcement soon: What are India’s options

The world is bracing up for the key reciprocal tariff announcements by US President Donald Trump. He has promised to “unveil a massive tariff plan on Liberation Day.” This is in addition to tariffs already imposed on aluminum, steel and autos, along with increased tariffs on all goods from China. The question that is relevant for us at the moment is how will it impact India and what are the options for us?

Can India reduce tariff to minimise impact?

While India could be among the worst hit nations as per broad reciprocal differentials, it needs to be also taken into consideration that some key susceptible sectors (Auto, Pharma, Electronics) are far better placed than feared. However, there are some like apparel and Gems/Jewellery are the most exposed.

Gaura SenGupta, chief economist at IDFC First Bank explained that increasing crude imports could offer some breathing space to India , “Tariff differentials is maximum on agriculture products . As per our calculation tariff differentials on agriculture products is 55.6%. It’s likely that India reduces tariffs on this segment which accounts for 4.4% share in total imports from the US. Other segments where tariffs could be reduced are pharma, stones and precious stones, electrical machinery, transport vehicles. India could offer to increase crude oil imports from US which accounts for 31% share in overall imports from US.”

ALSO READTrump Tariffs: Will India’s auto sector face a roadblock? Explained

Garima Kapoor, Economist and Executive Vice President, Elara Capital added that, “India’s immediate option would be to allow market access to American goods and negotiate trade deal. Eventually reducing tariffs and allowing the economy to open up is going to be beneficial for India in mid to long-term.”

India may argue for broad country-level tariff

Many industry observers believe that the Trump administration has been using tariff threats largely as a tool to extract concessions from affected countries but “simply accepting these concessions is not the only option for India.” added economists at Emkay Global.

According to Manoranjan Sharma, Chief Economist, Infomerics Ratings, “While “no trade is free”, as the globally acclaimed Harvard economist Dani Rodrik stressed, it must be realized that one size does not fit all. Unlike the US, India’s high tariffs are WTO (World Trade Organization) compliant. Given India’s wide tariff differential with the US,

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth